Breathe Well Live Well
|
German co's patent for asthma drug revoked
Times of India MUMBAI: India's Patent Office has revoked a patent on asthma drug, Spiriva (tiotropium bromide monohydrate) held by German major Boehringer Ingelheim on an opposition filed by generic company, Cipla. The patent was revoked on grounds that it lacks … |
View full post on asthma – Google News
 MedPage Today |
Merck & Co's asthma drug Singulair faces US generic onslaught
PMLiVE The Food and Drug Administration (FDA) has approved the first generic versions of Merck & Co's blockbuster asthma and allergy drug Singulair. The US regulator granted ten companies licences to market their own version of Singulair (motelukast) for use … Israel : TEVA bags approval from FDA to market generic asthma treatment … New generic Singulair could save asthma sufferers big bucks Generic Singulair Approved |
View full post on asthma – Google News